Actinium Pharmaceuticals Inc (ATNM) Short Interest Update
Actinium Pharmaceuticals Inc (NYSE:ATNM) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 2,109,473 shares, an increase of 43.5% from the September 15th total of 1,469,849 shares. Based on an average daily volume of 1,513,728 shares, the days-to-cover ratio is presently 1.4 days. Currently, 4.1% of the company’s shares are short sold.
Actinium Pharmaceuticals (NYSE:ATNM) traded down 3.97% during trading on Tuesday, hitting $1.16. The stock had a trading volume of 949,560 shares. The firm’s 50 day moving average is $1.64 and its 200 day moving average is $1.77. Actinium Pharmaceuticals has a 1-year low of $1.12 and a 1-year high of $3.50. The firm’s market cap is $55.35 million.
About Actinium Pharmaceuticals
Actinium Pharmaceuticals, Inc (Actinium) is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its alpha particle immunotherapy platform and other related technologies. The Company’s products include Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), and Iomab-B, an antibody-drug construct containing iodine 131 (I-131).
Receive News & Stock Ratings for Actinium Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Actinium Pharmaceuticals Inc and related stocks with our FREE daily email newsletter.